Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DRD1 and DRD4 are differentially expressed in breast tumors and breast cancer stem cells: pharmacological implications

1 Nov 2022

Abstract excerpt

Background: Abnormal expression of dopamine receptors (DRs) has been described in multiple tumors, but their roles in breast cancer are inconclusive or contradictory since evidence of pro- and anti-tumoral effects have been reported. Herein, we analyzed the expression of DRs in breast cancer, especially in the subpopulation of cancer stem cells (CSCs), and evaluated the functional role of the receptors by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Breast Cancer Therapies
Share to Cancer Cells and Metastasis
Share to Cancer, Stress, Anesthesia, and Immune Response

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36523297
DOI: 10.21037/tcr-22-783

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DRD1 and DRD4 are differentially expressed in breast tumors and breast cancer stem cells: pharmacological implicationsPMID 36523297Read ↗

In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.Semantic proximity Read ↗

Chlorpyrifos and tamoxifen co-pretreatment promotes stem-like phenotype and upregulation of anti-estrogen therapy resistance markers in ERα breast cancer cellsSemantic proximity Read ↗

DRD4 promotes chemo-resistance and cancer stem cell-like phenotypes by mediating the activation of the Akt/β-catenin signaling axis in liver cancer.Semantic proximity Read ↗

Dopamine Receptor Gene (DRD1-DRD5) Expression Changes as Stress Factors Associated with Breast CancerSemantic proximity Read ↗

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.Semantic proximity Read ↗

Estrogen Receptor β4 Regulates Chemotherapy Resistance and Induces Cancer Stem Cells in Triple Negative Breast CancerSemantic proximity Read ↗

Expression Profiles of Dopamine-Related Genes and miRNAs Regulating Their Expression in Breast CancerSemantic proximity Read ↗

Hypomethylation of DRD2 promotes breast cancer through the FLNA-ERK pathwaySemantic proximity Read ↗

Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancerSemantic proximity Read ↗

Inhibition of dopamine receptor D1 signaling promotes human bile duct cancer progression via WNT signaling.Semantic proximity Read ↗

Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 ReceptorSemantic proximity Read ↗

The Dopamine D2 Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma Cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.